EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57

Abstract

CLINICOPATHOLOGICAL CORRELATION OF HODGKIN LYMPHOMA AN IMMUNOPROFILE AND REVIEW OF LITERATURE

Nafisa Awadh Mansoor* and Sultan Al-Kubati

ABSTRACT

Introduction: Hodgkin lymphoma (HL) is a lymphoid malignancy that amounts for less than 1% of all de novo neoplasms occurring every year globally and nearly 30% of all lymphomas. Objectives: To evaluate the expression of several immunohistochemical markers on formalin fixed tissue, paraffin embedded sections of Hodgkin lymphoma subtypes and correlate them with age, sex and site. Methods: A total of 14 cases of Hodgkin lymphoma collected during two years 2012-2013. H&E, IHC were done. The markers used were CD30,CD15, CD20,CD3, LCA, EMA using En Vision system. Results: All cases were Classical Hodgkin lymphoma (cHL), 42.9% were males, 57.1% were females. nodular sclerosis 14.3% were males, 42.9% were females with a total of 57.1%, with M:F ratio 1:3, mixed cellularity 21.4% were males and 14.3% were females, with a total of 35.7%, with the M:F ratio 1.5:1, unclassified cHL was a male patient 7.1%. The most common age group affected was ≤ 29 (64.3%) followed by 30-59, (21.4%). Most of the cases were nodal 92.9% with cervical anatomic localization predominant 50% and only 7.1% extranodal in the breast which is a rare location. In respect to phenotyping, CD30 was positive in all the cases 100%, CD15 was positive in 50% of the cases, CD20 was positive in 14.3% of the cases, CD3, LCA, EMA were negative in all. Conclusions: IHC is a very important investigation for HL and other lymphomas and for immunotherapy. The most common subtype of HL was nodular sclerosis with female predominant, followed by mixed cellularity. The most common age group affected was ≤ 29 (64.3%). Most of the cases were nodal with cervical predominant, except one extranodal in the breast. CD30 expressed in all cases, while CD15 expressed in 50%, CD20 expressed in 14.3%.

Keywords: Hodgkin lymphoma, immunhistochemistry, Yemen.


[Full Text Article]

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 October 2021 Issue has been Published, Kindly check it on http://www.ejpmr.com/home/current_issues

  • EJPMR: OCTOBER ISSUE PUBLISHED

    OCTOBER Issue has been successfully launched on 1 October 2021.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI )